$BLFS. breakout candle. $2.07 Might pull back be
Post# of 98046
(Total Views: 211)
Posted On: 02/12/2017 12:09:10 PM
$BLFS. breakout candle. $2.07
Might pull back below upper bollie $1.92
Nasdaq CM
Website
BioLife Solutions Announces 2016 Revenue Growth of 28%
2017 Guidance Provided 1/12/17
100% x 100% Strong Buy
10 K/A 12/9/2016
Last 10 trades
Stock technical analysis
Shares Outstanding 12.88M
Float 6.3M
% Held by Insiders 51.44%
% Held by Institutions 3.40%
Shares Short 199.37k
Short Ratio 5.8
Short % of Float 6.04%
Shares Short (prior month) 208.77k
The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services.
Might pull back below upper bollie $1.92
Nasdaq CM
Website
BioLife Solutions Announces 2016 Revenue Growth of 28%
2017 Guidance Provided 1/12/17
100% x 100% Strong Buy
10 K/A 12/9/2016
Last 10 trades
Stock technical analysis
Shares Outstanding 12.88M
Float 6.3M
% Held by Insiders 51.44%
% Held by Institutions 3.40%
Shares Short 199.37k
Short Ratio 5.8
Short % of Float 6.04%
Shares Short (prior month) 208.77k
The Company’s proprietary HypoThermosol® and CryoStor® platform of solutions are highly valued in the biobanking, drug discovery, and regenerative medicine markets. BioLife’s biopreservation media products are serum-free and protein-free, fully defined, and are formulated to reduce preservation-induced cell damage and death. BioLife’s enabling technology provides commercial companies and clinical researchers significant improvement in shelf life and post-preservation viability and function of cells, tissues, and organs. BioLife also performs contract aseptic media formulation, fill, and finish services.
(0)
(0)Scroll down for more posts ▼